Shire to Acquire Movetis and Expand its Gastrointestinal Portfolio
By Heather Cartwright
Pharma Deals Review: Vol 2010 Issue 7 (Table of Contents)
Published: 8 Sep-2010
DOI: 10.3833/pdr.v2010.i7.1365 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Shire has made a conditional offer for the Belgian speciality gastrointestinal (GI) company Movetis valued at US$565 M (€428 M)...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS